Navigation Links
Inclinix, Inc. Announces Executive Management Team Changes
Date:2/22/2008

WILMINGTON, N.C., Feb. 22 /PRNewswire/ -- Inclinix, Inc., an enrollment contract research organization (CRO) and provider of clinical trial recruitment solutions, announced today the following changes to its executive management team:

-- Steven M. Agnoff, has joined the company in the position of Vice

President of Marketing and Product Management. In this role, Mr. Agnoff

provides strategic direction to the corporate marketing and product

marketing functions of the company and oversees product management

efforts. Prior to joining Inclinix, Mr. Agnoff held executive

leadership and business development roles with organizations including

PDI, Inc., PharmaKon, Fenner PLC, Efson, Inc. and Interroll

Corporation.

-- Daniel D. Marks, has joined the company as Vice President of Corporate

Development. In this role, Mr. Marks is responsible for the evaluation

and execution of Inclinix's strategic investments, joint ventures and

acquisitions. Before joining Inclinix, he held executive management

roles within the technology and medical services sectors.

-- Jeffrey L. Bagshaw, has been named Senior Vice President of Sales. In

this role, Mr. Bagshaw is responsible for leading sales operations of

Inclinix. Prior to this role, he served as vice president of medical

marketing and communications at Inclinix. Prior to joining Inclinix,

Mr. Bagshaw held sales and marketing leadership roles at organizations

including Hoffman La Roche, Bristol Myers Squibb and Exact Sciences.

Newly-reporting to Mr. Bagshaw is:

-- Susan A. Jalbert, who has joined the company as Director of North

American Sales. In this role, Ms. Jalbert has responsibility for

managing strategic client relationship development and tactical sales

efforts with Inclinix's expanded sales team. Prior to joining

Inclinix, Ms. Jalbert held sales and business development leadership

positions at Medidata Solutions, Relsys International, Inc., Domain

Pharma Corporation, Neuromedical Systems, Inc. and the Corning

Nichols Institute. Now reporting to Ms. Jalbert are:

- Ashley Amstutz, sales executive;

- Jeffrey Cazeault, sales executive;

- Svetlana Gorodetsky, sales executive;

- Matt Granger, sales executive;

- Askold Kozbur, sales executive;

- Tom McCollum, senior sales executive;

- Stephen Scaldaferri, sales executive; and

- Christine Ward, sales executive.

CEO and President J. Tobin Geatz said: "We are excited to have these accomplished industry professionals on board to strengthen our leadership team. Having previously helped other innovative companies accelerate their revenues and growth paths, these executives, without doubt, are equipped and ready to guide Inclinix during this time of tremendous growth."

About Inclinix

Founded in 1999, Inclinix, Inc., is the industry's Enrollment CRO. Inclinix's IQM(TM) Intelligent Enrollment process uses technology to amplify traditional services and is proven to accelerate trials for pharmaceutical, biotechnology and medical-device organizations. In addition to its clinical research-related offerings, Inclinix provides strategic medical marketing communications and adherence services to the healthcare industry. For more information on Inclinix, visit http://www.inclinix.com


'/>"/>
SOURCE Inclinix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HCA Announces Preliminary Results for Its Debt Tender Offer
2. STAAR Surgical Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
3. Air Methods Announces New Chief Operating Officer
4. Pacific Fertility Center Announces Breakthrough in Egg Freezing Technology
5. Neurochem announces departure of two members of management team
6. Emergency Dentist 24/7(TM) Announces Worldwide Licensing Program
7. LCA-Vision Announces Quarterly Dividend Payment
8. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
9. China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results
10. IDM Pharma Announces Compliance With NASDAQ Minimum Bid Price Requirements
11. Derma Sciences Announces Several Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming APWCA Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... National recruitment firm ... life sciences executive with extensive sequencing and genomics experience, as Vice President of North ... Ms. Hill will be responsible for leading the sales team in the commercialization of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
Breaking Medicine Technology: